Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China · Delayed Price · Currency is CNY 4.900
+0.090 (1.87%)
Oct 23, 2026, 3:04 PM CST
SHE:300039 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,011 | 1,153 | 1,473 | 1,594 | 1,119 | 1,101 |
Revenue Growth | -19.05% | -21.76% | -7.57% | 42.47% | 1.66% | 21.21% |
Gross Profit Gross Profit Growth | 810.65 | 930.45 | 1,200 | 1,282 | 871 | 866.48 |
Operating Income Operating Income Growth | 241.33 | 263.48 | 355.02 | 309.75 | 181.49 | 119.35 |
Net Income Net Income Growth | 258.56 | 278.58 | 375.58 | 327.87 | 190.8 | 140.11 |
Earnings Per Share EPS Growth | 0.25 | 0.27 | 0.36 | 0.31 | 0.18 | 0.13 |
EPS Growth | -27.25% | -25.84% | 14.54% | 71.88% | 36.17% | 31.97% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Industry Industry Growth | 1,008 | 1,149 | 1,471 | 1,591 | 1,117 | 1,099 |
Unallocated Other Unallocated Other Growth | - | 3.33 | 1.9 | 3.03 | 2.25 | 1.29 |
Total Total Growth | 1,011 | 1,153 | 1,473 | 1,594 | 1,119 | 1,101 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,236 | 1,593 | 1,698 | 751.95 | 830.76 | 1,455 |
Total Debt Total Debt Growth | 5.41 | 4.08 | 5.42 | - | - | - |
Net Cash (Debt) Net Cash Growth | 1,230 | 1,589 | 1,693 | 751.95 | 830.76 | 1,455 |
Net Cash Growth | -35.00% | -6.16% | 125.12% | -9.49% | -42.88% | 2.28% |
Net Cash Per Share Net Cash Per Share Growth | 1.18 | 1.52 | 1.62 | 0.72 | 0.79 | 1.39 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 179.72 | 230.74 | 278.95 | 382.66 | 376.42 | 126.08 |
Capital Expenditures CapEx Growth | -18.03 | -27.04 | -140.52 | -29.08 | -31.62 | -42.55 |
Free Cash Flow Free Cash Flow Growth | 161.7 | 203.7 | 138.43 | 353.59 | 344.8 | 83.53 |
Free Cash Flow Growth | -44.35% | 47.16% | -60.85% | 2.55% | 312.79% | -64.71% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 80.19% | 80.72% | 81.47% | 80.44% | 77.85% | 78.73% |
Operating Margin | 23.87% | 22.86% | 24.10% | 19.43% | 16.22% | 10.84% |
Pretax Margin | 29.58% | 27.94% | 29.47% | 24.06% | 20.22% | 15.41% |
Profit Margin | 25.58% | 24.17% | 25.49% | 20.57% | 17.05% | 12.73% |
FCF Margin | 16.00% | 17.67% | 9.40% | 22.18% | 30.82% | 7.59% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.130 | 0.100 | 0.100 | 0.060 | 0.050 |
Dividend Per Share Growth | 30.00% | 30.00% | 0% | 66.67% | 20.00% | 66.67% |
Dividend Yield | 4.08% | 2.16% | 1.62% | 1.50% | 0.74% | 0.81% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 19.82 | 22.64 | 17.21 | 21.22 | 44.19 | 45.99 |
Forward PE | - | 24.15 | 24.15 | 24.15 | 24.15 | 24.15 |
P/FCF Ratio | 31.70 | 30.96 | 46.70 | 19.67 | 24.45 | 77.14 |
PS Ratio | 5.07 | 5.47 | 4.39 | 4.36 | 7.54 | 5.86 |